题名 | Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment |
作者 | |
通讯作者 | Zhang, Jianglin; Zhang, Jiaheng |
发表日期 | 2023-04-01
|
DOI | |
发表期刊 | |
ISSN | 2373-9878
|
卷号 | 9期号:6 |
摘要 | Obesity is currently a prerequisite for more than 70% of adults, including chronic obesity and long-term obesity. With the increase of diabetes patients in the world, it is urgent to develop effective oral drugs to replace insulin. However, the gastrointestinal tract is a main obstacle to oral drug preparations. Here, a highly effective oral drug was developed, mainly formulated as an ionic liquid (IL) prepared by L-(-)-carnitine and geranic acid. Density functional theory (DFT) calculations showed that L-(-)-carnitine and geranic acid can exist stably through hydrogen bonding. IL can significantly enhance the transdermal transport of drugs. In vitro study of intestinal permeability showed that particles formed by IL can prevent the absorption of intestinal fat. Compared with the control group, oral administration of IL (10 mL kg-1) significantly reduced blood glucose, white adipose tissue in the liver and epididymis, and the expression of SREBP-1c and ACC in IL. Therefore, these results and high-throughput sequencing analysis showed that IL can effectively reduce the intestinal absorption of adipose tissue to reduce blood glucose. IL has good biocompatibility and stability. Therefore, IL has a certain application value in the field of oral drug-delivery carriers, which provides an effective means for the treatment of diabetes and is a potential tool to solve the epidemic of obesity. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 第一
; 通讯
|
资助项目 | National Natural Science Foundation of China["82073018","21703218"]
; Shenzhen Science and Technology Innovation Committee["JCYJ20180507183907224","KQTD20170809110344233"]
; Economic, Trade and Information Commission of Shenzhen Municipality through the Graphene Manufacture Innovation Center[201901161514]
; Guangdong Province Covid-19 Pandemic Control Research Fund[2020KZDZX1220]
|
WOS研究方向 | Materials Science
|
WOS类目 | Materials Science, Biomaterials
|
WOS记录号 | WOS:000984468900001
|
出版者 | |
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:3
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/536212 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Jinan Univ, Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1,Dept Dermatol,Clin Med Coll 2, Shenzhen 518020, Guangdong, Peoples R China 2.Natl Clin Res Ctr Skin Dis, Candidate Branch, Shenzhen 518020, Guangdong, Peoples R China 3.Geriatr Ctr, Dept Shenzhen Peoples Hosp, Shenzhen 518020, Guangdong, Peoples R China 4.Harbin Inst Technol Shenzhen, Sauvage Lab Smart Mat, Shenzhen 518055, Peoples R China 5.Harbin Inst Technol Shenzhen, Res Ctr Printed Flexible Elect, Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China 6.Univ Idaho, Dept Chem, Moscow, ID 83844 USA |
第一作者单位 | 南方科技大学第一附属医院 |
通讯作者单位 | 南方科技大学第一附属医院 |
第一作者的第一单位 | 南方科技大学第一附属医院 |
推荐引用方式 GB/T 7714 |
Lu, Beibei,Wu, Chengyu,Zhang, Jichuan,et al. Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment[J]. ACS BIOMATERIALS SCIENCE & ENGINEERING,2023,9(6).
|
APA |
Lu, Beibei,Wu, Chengyu,Zhang, Jichuan,Zhang, Jianglin,&Zhang, Jiaheng.(2023).Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment.ACS BIOMATERIALS SCIENCE & ENGINEERING,9(6).
|
MLA |
Lu, Beibei,et al."Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment".ACS BIOMATERIALS SCIENCE & ENGINEERING 9.6(2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论